Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 8,076,000 | 7,979,000 | 7,535,000 | 7,765,000 | 7,656,000 |
| Cost of Goods | 3,358,000 | 3,279,000 | 3,160,000 | 3,191,000 | 3,166,000 |
| Gross Profit | 4,718,000 | 4,700,000 | 4,375,000 | 4,574,000 | 4,490,000 |
| Operating Expenses | 3,520,000 | 3,494,000 | 3,636,000 | 3,409,000 | 3,495,000 |
| Operating Income | 1,198,000 | 1,206,000 | 739,000 | 1,165,000 | 995,000 |
| Interest Expense | 167,000 | 168,000 | 171,000 | 186,000 | 203,000 |
| Other Income | 72,000 | 64,000 | 64,000 | -32,000 | -74,000 |
| Pre-tax Income | 1,103,000 | 1,102,000 | 632,000 | 947,000 | 718,000 |
| Income Tax | 143,000 | 96,000 | -40,000 | 292,000 | 166,000 |
| Net Income Continuous | 960,000 | 1,006,000 | 672,000 | 655,000 | 552,000 |
| Net Income Discontinuous | N/A | N/A | 0 | -1,000 | 11,000 |
| Net Income | $960,000 | $1,006,000 | $672,000 | $654,000 | $563,000 |
| EPS Basic Total Ops | 0.54 | 0.57 | 0.38 | 0.36 | 0.32 |
| EPS Basic Continuous Ops | 0.54 | 0.57 | 0.38 | 0.37 | 0.31 |
| EPS Basic Discontinuous Ops | 0.00 | 0.00 | 0.00 | -0.01 | 0.01 |
| EPS Diluted Total Ops | 0.53 | 0.56 | 0.38 | 0.37 | 0.32 |
| EPS Diluted Continuous Ops | 0.53 | 0.56 | 0.38 | 0.37 | 0.31 |
| EPS Diluted Discontinuous Ops | 0.00 | 0.00 | 0.00 | N/A | 0.01 |
| EBITDA(a) | $1,952,000 | $1,957,000 | $1,492,000 | $1,928,000 | $1,808,000 |